Application no. and date | 08732084.2 (espacenet) (Federated) (European Patent Register), 20080313 | Patent/reg. no. and date | DK/EP 2125698, 20160831 | Publication date | 20091202 | Priority no. and date | US 895049 P, 20070315, US 944399 P, 20070615 | EP pub. no. and date |
EP 2125698 20091202 | Effective date | | Applicant/owner | Auspex Pharmaceuticals, Inc., 3333 North Torrey Pine Court, Suite 400
La Jolla, CA 92037, US | Applicant ref. no. | P59273DK01 | Inventor | WOO, Soon, Hyung, 1261 Liberty Way, Suite C
Vista, CA 92081-8356, US, GANT, Thomas, G., 1261 Liberty Way, Suite C
Vista, CA 92081-8356, US, SEPEHR, Sarshar, 1261 Liberty Way, Suite C
Vista, CA 92081-8356, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | C07B 59/00 (2006.01) , C07C 211/64 (2006.01) , C07C 215/64 (2006.01) , C07C 217/74 (2006.01) , C07D 265/16 (2006.01) | Title | DEUTERERET d9-VENLAFAXIN | Int. application no. | US2008056780 | Int. publication no. | WO2008140859 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|